EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Effect of LDL-Cholesterol Levels and Oral Atorvastatin on Outcomes After Pipeline Therapy for Intracranial Aneurysms

Xin Feng iD, Chi Huang iD, Xin Tong iD, Zhuohua Wen iD, Yajun Zhu iD, Mengshi Huang iD, Jiancheng Lin, Jiwan Huang iD, Hao Yuan iD, Anqi Xu iD, Gengwu Ma iD, Runze Ge iD und 8 weitere

Stroke · 2025

DOI: 10.1161/strokeaha.124.049833 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Stroke, 2025. Verfasst von Xin Feng und 19 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cere…. Hauptthemen laut MEDLINE: Atorvastatin, Intracranial Aneurysm, Cholesterol, LDL, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We aimed to determine the effects of statin treatment on outcomes of pipeline embolization device therapy for intracranial aneurysms in relation to LDL (low-density lipoprotein) cholesterol levels. METHODS: Using data from the SESIA registry (Safety and Efficacy of Stent Deployment for Intracranial Aneurysms), we enrolled participants who underwent pipeline embolization device implantation at 4 centers in China (2018–2022). Statin users (atorvastatin 20 mg daily, for ≥3 days and ≥6 months preprocedurally and postprocedurally, respectively) were matched with nonstatin users (1:1) using propensity scores and further adjusted by inverse probability of treatment weighting, balancing for baseline characteristics, procedural details, and lipid levels (based on East Asian profiles). Study outcomes include perioperative complications, aneurysmal occlusion, in-stent stenosis, and clinical prognosis at the latest follow-up. Multivariable analyses using logistic and Cox regression models adjusted for these factors in both prematched and postmatched cohorts, evaluating the role of lipid modification in subgroups. RESULTS: Of the 1558 patients screened, 1193 (53.75±11.07 years, 69.4% females; statin: n=603, nonstatin: n=590) were enrolled with 3- to 48-month follow-up. In the matched cohort (352 pairs), statin treatment reduced the incidences of perioperative cerebrovascular (2.0% versus 8.5%, P =0.001) and follow-up ischemic (1.7% versus 5.1%, P =0.020) complications. Multivariable analyses in participants with baseline LDL-cholesterol ≥2.59 mmol/L showed that statin treatment was associated with fewer perioperative cerebrovascular complications (odds ratio, 0.371 [95% CI, 0.195–0.705]; P =0.002), in-stent stenosis (hazard ratio, 0.433 [95% CI, 0.269–0.698]; P =0.001), and follow-up ischemic events (hazard ratio, 0.315 [95% CI, 0.135–0.733]; P =0.007; P values for interaction were 0.671, 0.009, and 0.507, respectively, versus

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtorvastatinIntracranial AneurysmCholesterol, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsEmbolization, TherapeuticHumansFemaleMaleMiddle AgedTreatment OutcomeAgedRegistriesAdultStentsAdministration, Oral

Stichwörter der Autor:innen

atorvastatinhydroxymethylglutaryl-CoA reductase inhibitorsintracranial aneurysmsischemic strokelipoproteins

Substanzen

AtorvastatinCholesterol, LDLHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Neurosurgery Center, Department of Cerebrovascular Surgery, Engineering Research Center of Diagnostic and Therapeutic Technology and Devices for Cerebrovascular Diseases, Ministry of Education, Zhujiang Hospital, Southe…
  • Department of Interventional Neuroradiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, People's Republic of China (X.T., A.L.).
  • Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, People's Republic of China (Y.Z., Z.G.).
  • Department of Neurosurgery, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China (C.P.).

ORCID-Profile: Xin Feng, Chi Huang, Xin Tong, Zhuohua Wen, Yajun Zhu, Mengshi Huang, Jiwan Huang, Hao Yuan, Anqi Xu, Gengwu Ma, Runze Ge, Can Li, Shixing Su, Xifeng Li, Zongduo Guo, Aihua Liu, Chuanzhi Duan

Zitieren

APA

Feng, X., Huang, C., Tong, X., Wen, Z., Zhu, Y., Huang, M., Lin, J., Huang, J., Yuan, H., Xu, A., Ma, G., Ge, R., Li, C., Peng, C., Su, S., Zhang, X., Li, X., Guo, Z., Liu, A., & Duan, C. (2025). Effect of LDL-Cholesterol Levels and Oral Atorvastatin on Outcomes After Pipeline Therapy for Intracranial Aneurysms. Stroke. https://doi.org/10.1161/strokeaha.124.049833

Vancouver

Feng X, Huang C, Tong X, Wen Z, Zhu Y, Huang M, et al. Effect of LDL-Cholesterol Levels and Oral Atorvastatin on Outcomes After Pipeline Therapy for Intracranial Aneurysms. Stroke. 2025. doi:10.1161/strokeaha.124.049833

BibTeX
@article{Feng2025,
  author = {Feng, Xin and Huang, Chi and Tong, Xin and Wen, Zhuohua and Zhu, Yajun and Huang, Mengshi and Lin, Jiancheng and Huang, Jiwan and Yuan, Hao and Xu, Anqi and Ma, Gengwu and Ge, Runze and Li, Can and Peng, Chao and Su, Shixing and Zhang, Xin and Li, Xifeng and Guo, Zongduo and Liu, Aihua and Duan, Chuanzhi},
  title = {Effect of LDL-Cholesterol Levels and Oral Atorvastatin on Outcomes After Pipeline Therapy for Intracranial Aneurysms},
  journal = {Stroke},
  year = {2025},
  doi = {10.1161/strokeaha.124.049833}
}
Kostenlos starten →